Bayer AG is in mediation to potentially settle thousands of U.S. lawsuits claiming that the companyâ€™s Roundup weed killer causes cancer, but some legal experts said the cases raises novel questions that may prevent an easy settlement.
Legal experts outlined several obstacles the parties may face on the path towards settlement â€¦. Settlements involving drugs, medical devices or consumer goods often result in the addition of a warning label, a recall or the outright discontinuance of a product. Those steps generally close the door to future lawsuits, making settlement costs and risks predictable.
Bayer has never publicly considered pulling Roundup off the market. The company in June announced a $5.6 billion investment to research and develop a glyphosate alternative.
Plaintiffs lawyers, who claim the company manipulated the science, told Reuters they would insist on a cancer warning label as part of any Roundup settlement.
Such a warning has been rejected by the U.S. Environmental Protection Agency, which regulates pesticides and repeatedly has found glyphosate to be safe.
This is summary of the original article. Read the full, original article by Tina Bellon here:Â EXPLAINER – What are the obstacles to Bayer settling Roundup lawsuits?
Related article:Â Â Plaintiffs suing Monsanto over alleged carcinogenicity of herbicide glyphosate say EPA colluded with company